Not all patients have enough information to protect themselves from preventable heart attacks and strokes, a newly released questionnaire of European patients confirms.

Patient advocacy organisations across Europe are banding together to improve cardiovascular health.

Development of biosimilars has expanded patients’ treatment options by offering innovative medicine at lower costs than traditional biologics. So why are some nations slow to adopt biosimilars?

Physicians across Latin America are coming together to discuss a timely topic: what access to biosimilars means to their patients.

New medical guidelines often come with an intrinsic irony.

Weeks shy of the annual European Society of Cardiology Congress, new data from the United States shed light on the importance of cardiovascular prevention.

A recent survey of Europeans with gout offers a startling reminder that stigma can have real medical consequences.

The United Kingdom’s Brexit saga has captured the attention of the world.  But it’s also sparked concerns among British patients, researchers and health care advocates, who are asking: How will health research and innovation fare after the UK severs ties with the European Union? Research on cardiovascular disease provides an apt example.  According to the … Continued